BioXcel Therapeutics, Inc.BioXcel Therapeutics, Inc.BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.

No trades
See on Supercharts

BTAI fundamentals

The current financial position of BioXcel Therapeutics, Inc.

Total assets of BTAI for Q2 24 is 65.44 M USD, 20.51% less than the previous Q1 24. And total liabilities decreased by 9.66% in Q2 24 to 139.74 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total assets
Total liabilities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Total assetsYoY growth
Total equityYoY growth